About Indus Biotech
Indus Biotech is a company based in Pune (India) founded in 1997 by Ranjeet Palliyil Srinivasan. Indus Biotech has raised $5.27 million across 1 funding round. The company has 138 employees as of March 30, 2024. Indus Biotech offers products and services including Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and Sugaheal®. Indus Biotech operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
- Headquarter Pune, India
- Employees 138 as on 30 Mar, 2024
- Founders Ranjeet Palliyil Srinivasan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Indus Biotech Limited
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$8.43 M (USD)-28.87as on Mar 31, 2023
-
Net Profit
$1.39 M (USD)-52.21as on Mar 31, 2023
-
EBITDA
$1.73 M (USD)-57.1as on Mar 31, 2023
-
Total Equity Funding
$5.27 M (USD)
in 1 rounds
-
Latest Funding Round
$5.27 M (USD), Series A
Jun 01, 2007
-
Investors
Not available
-
Employee Count
138
as on Mar 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Indus Biotech
Indus Biotech offers a comprehensive portfolio of products and services, including Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and Sugaheal®.
Increases testosterone levels through natural, clinically proven extracts.
Supports blood sugar management with high-fiber fenugreek extract.
Provides grape seed extract for improved health and circulation benefits.
Boosts lean mass and strength via fenugreek-based formulation.
Helps maintain healthy glucose levels in diabetes management.
Alleviates allergic rhinitis symptoms using cinnamon bark extract.
Funding Insights of Indus Biotech
Indus Biotech has successfully raised a total of $5.27M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.27 million completed in June 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Indus Biotech
Investment portfolio details for Indus Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Indus Biotech
Detailed financials for Indus Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Indus Biotech Comparisons
Peer comparison for Indus Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Indus Biotech
Indus Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and development research services are provided.
|
Detailed competitors of Indus Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Indus Biotech
Complete news archive for Indus Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indus Biotech
Indus Biotech was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Indus Biotech is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Indus Biotech is a funded company, having raised a total of $5.27M across 1 funding round to date.
As of Mar 30, 2024, the latest employee count at Indus Biotech is 138.
Annual revenue of Indus Biotech is $8.43M as on Mar 31, 2023.
Founded in 1997, Indus Biotech operates as a drug discovery company in the biotechnology sector, based in Pune, India. Focus is placed on identifying and developing treatments for autoimmune, oncology, central nervous system, infectious, and lifestyle diseases. Current products encompass torabolic for mass building, testosurge for testosterone bioavailability enhancement, biocreat for creatine delivery to muscle tissue, and testofen for libido support. Operations emphasize research and product innovation.
Indus Biotech's top competitors include Evotec, Crown Bioscience and NIH.
Indus Biotech offers Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and 2 more products and services.